4 assets in Acquired Immunodeficiency

Therapeutic assets addressing Acquired Immunodeficiency, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Human Normal Immunoglobulin (Ivig) Acquired Immunodeficiency	Takeda	P3	B (60)
Igpro20 Acquired Immunodeficiency	CSL Behring	P3	B (60)
Ergotidine Acquired Immunodeficiency	Sahlgrenska University Hospital	P2	CCC (53)